KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Colorectal Cancer · Pancreatic Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing, Jiangsu, China
Study leads
Baorui Liu
Study Chair
Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University